Literature DB >> 3497170

Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.

P H Gilligan, P A Gage, D F Welch, M J Muszynski, K R Wait.   

Abstract

During a 1-year period, the prevalence of thymidine-dependent (TD) Staphylococcus aureus in patients at two geographically distinct cystic fibrosis (CF) centers was determined. Of 200 CF patients who had their respiratory secretions cultured, 95 harbored S. aureus, and 20 (21%) had TD S. aureus as their predominant staphylococcal isolate. All 20 TD S. aureus-positive patients had received trimethoprim-sulfamethoxazole for an average of 30.9 months. It was also observed that TD S. aureus exhibited aberrant colony morphologies or did not grow on media commonly used in CF centers for S. aureus isolation, suggesting that this organism could be missed by routine culture methods. In contrast, all 20 isolates had typical staphylococcal morphology on mannitol salt agar after 48 h of incubation. Mannitol salt agar is recommended for primary isolation of TD S. aureus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497170      PMCID: PMC269188          DOI: 10.1128/jcm.25.7.1258-1261.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Cystic fibrosis.

Authors:  R E Wood; T F Boat; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1976-06

2.  Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.

Authors:  L D Sabath; C Garner; C Wilcox; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

Review 3.  Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole.

Authors:  R L Then
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

Review 4.  The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.

Authors:  M I Marks
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

5.  A new medium for the isolation of Staphylococcus aureus, including thymine requiring strains, from sputum.

Authors:  R Howden
Journal:  Med Lab Sci       Date:  1981-01

6.  Isolation of Staphylococcus aureus from sputum in cystic fibrosis.

Authors:  P D Sparham; D I Lobban; D C Speller
Journal:  J Clin Pathol       Date:  1978-10       Impact factor: 3.411

7.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

Review 8.  Antibiotic use in cystic fibrosis.

Authors:  H W Kelly; C Lovato
Journal:  Drug Intell Clin Pharm       Date:  1984-10

9.  Effect of thymidine on activity of trimethoprim and sulphamethoxazole.

Authors:  A Stokes; R W Lacey
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

  9 in total
  31 in total

Review 1.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection.

Authors:  Awele Maduka-Ezeh; Maria Teresa Seville; Shimon Kusne; Holenarasipur R Vikram; Janis E Blair; Kerryl Greenwood-Quaintance; Francisco Arabia; Robin Patel
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 3.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

4.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

5.  Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.

Authors:  Johannes Zander; Silke Besier; Hanns Ackermann; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

Review 6.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

7.  Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection.

Authors:  Konrad Trülzsch; Harald Hoffmann; Christiane Keller; Sören Schubert; Lutz Bader; Jürgen Heesemann; Andreas Roggenkamp
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus.

Authors:  Johannes Zander; Silke Besier; Stephan H Saum; Faramarz Dehghani; Stefan Loitsch; Volker Brade; Thomas A Wichelhaus
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

Review 10.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.